O	0	7	Ectopic	Ectopic	JJ	B-NP
O	8	15	decorin	decorin	NN	I-NP
O	16	26	expression	expression	NN	I-NP
O	27	29	up	up	RB	B-ADVP
O	29	30	-	-	HYPH	B-NP
O	30	39	regulates	regulate	VBZ	B-VP
O	40	44	VEGF	VEGF	NN	B-NP
O	45	55	expression	expression	NN	I-NP
O	56	58	in	in	IN	B-PP
O	59	64	mouse	mouse	NN	B-NP
B-Cell	65	73	cerebral	cerebral	JJ	I-NP
I-Cell	74	85	endothelial	endothelial	JJ	I-NP
I-Cell	86	91	cells	cell	NNS	I-NP
O	92	95	via	via	IN	B-PP
O	96	106	activation	activation	NN	B-NP
O	107	109	of	of	IN	B-PP
O	110	113	the	the	DT	B-NP
O	114	127	transcription	transcription	NN	I-NP
O	128	135	factors	factor	NNS	I-NP
O	136	139	Sp1	Sp1	NN	B-NP
O	139	140	,	,	,	O
O	141	150	HIF1alpha	HIF1alpha	NN	B-NP
O	150	151	,	,	,	O
O	152	155	and	and	CC	O
O	156	161	Stat3	Stat3	NN	B-NP
O	161	162	.	.	.	O

O	163	165	We	We	PRP	B-NP
O	166	177	demonstrate	demonstrate	VBP	B-VP
O	178	182	that	that	IN	B-SBAR
O	183	184	a	a	DT	B-NP
O	185	197	proteoglycan	proteoglycan	NN	I-NP
O	198	205	decorin	decorin	NN	I-NP
O	206	207	(	(	(	O
O	207	210	DCN	DCN	NN	B-NP
O	210	211	)	)	)	O
O	212	214	up	up	RB	B-ADVP
O	214	215	-	-	HYPH	B-NP
O	215	224	regulates	regulate	VBZ	B-VP
O	225	228	the	the	DT	B-NP
O	229	237	vascular	vascular	JJ	I-NP
O	238	249	endothelial	endothelial	JJ	I-NP
O	250	256	growth	growth	NN	I-NP
O	257	263	factor	factor	NN	I-NP
O	264	265	(	(	(	O
O	265	269	VEGF	VEGF	NN	B-NP
O	269	270	)	)	)	O
O	271	281	expression	expression	NN	B-NP
O	282	286	with	with	IN	B-PP
O	287	297	activation	activation	NN	B-NP
O	298	300	of	of	IN	B-PP
O	301	305	VEGF	VEGF	NN	B-NP
O	306	316	regulating	regulating	NN	I-NP
O	317	330	transcription	transcription	NN	I-NP
O	331	338	factors	factor	NNS	I-NP
O	339	342	Sp1	Sp1	NN	B-NP
O	342	343	,	,	,	O
O	344	351	hypoxia	hypoxia	NN	B-NP
O	351	352	-	-	HYPH	B-NP
O	352	361	inducible	inducible	JJ	I-NP
O	362	368	factor	factor	NN	I-NP
O	369	375	1alpha	1alpha	NN	I-NP
O	376	377	(	(	(	O
O	377	386	HIF1alpha	HIF1alpha	NN	B-NP
O	386	387	)	)	)	O
O	387	388	,	,	,	O
O	389	392	and	and	CC	O
O	393	399	signal	signal	NN	B-NP
O	400	410	transducer	transducer	NN	I-NP
O	411	414	and	and	CC	O
O	415	424	activator	activator	NN	B-NP
O	425	427	of	of	IN	B-PP
O	428	441	transcription	transcription	NN	B-NP
O	442	443	3	3	CD	I-NP
O	444	445	(	(	(	O
O	445	450	Stat3	Stat3	NN	B-NP
O	450	451	)	)	)	O
O	452	455	via	via	IN	B-PP
O	456	465	epidermal	epidermal	JJ	B-NP
O	466	472	growth	growth	NN	I-NP
O	473	479	factor	factor	NN	I-NP
O	480	488	receptor	receptor	NN	I-NP
O	489	490	(	(	(	O
O	490	494	EGFR	EGFR	NN	B-NP
O	494	495	)	)	)	O
O	495	496	,	,	,	O
O	497	504	mitogen	mitogen	NN	B-NP
O	504	505	-	-	HYPH	B-VP
O	505	514	activated	activate	VBN	B-NP
O	515	522	protein	protein	NN	I-NP
O	523	529	kinase	kinase	NN	I-NP
O	530	543	extracellular	extracellular	JJ	I-NP
O	544	550	signal	signal	NN	I-NP
O	550	551	-	-	HYPH	O
O	551	560	regulated	regulate	VBN	B-VP
O	561	567	kinase	kinase	NN	B-NP
O	568	569	1	1	CD	I-NP
O	569	570	/	/	SYM	B-NP
O	570	571	2	2	CD	I-NP
O	572	573	(	(	(	O
O	573	577	ERK1	ERK1	NN	B-NP
O	577	578	/	/	SYM	O
O	578	579	2	2	CD	B-NP
O	579	580	)	)	)	O
O	580	581	,	,	,	O
O	582	585	and	and	CC	O
O	586	593	protein	protein	NN	B-NP
O	594	600	kinase	kinase	NN	I-NP
O	601	602	B	B	NN	I-NP
O	603	604	(	(	(	O
O	604	607	AKT	AKT	NN	B-NP
O	607	608	)	)	)	O
O	609	617	pathways	pathway	NNS	B-NP
O	618	620	in	in	IN	B-PP
O	621	624	DCN	DCN	NN	B-NP
O	625	636	transfected	transfecte	VBN	I-NP
O	637	642	mouse	mouse	NN	I-NP
B-Cell	643	651	cerebral	cerebral	JJ	I-NP
I-Cell	652	663	endothelial	endothelial	JJ	I-NP
I-Cell	664	665	(	(	(	O
I-Cell	665	668	MCE	MCE	NN	B-NP
I-Cell	668	669	)	)	)	I-NP
I-Cell	670	675	cells	cell	NNS	I-NP
O	675	676	.	.	.	O

O	677	686	Treatment	Treatment	NN	B-NP
O	687	691	with	with	IN	B-PP
O	692	707	pharmacological	pharmacological	JJ	B-NP
O	708	718	inhibitors	inhibitor	NNS	I-NP
O	719	722	and	and	CC	O
O	723	728	small	small	JJ	B-NP
O	729	740	interfering	interfere	VBG	I-NP
O	741	745	RNAs	RNA	NNS	I-NP
O	746	752	reveal	reveal	VBP	B-VP
O	753	757	that	that	IN	B-SBAR
O	758	767	induction	induction	NN	B-NP
O	768	771	and	and	CC	O
O	772	782	activation	activation	NN	B-NP
O	783	785	of	of	IN	B-PP
O	786	789	Sp1	Sp1	NN	B-NP
O	789	790	,	,	,	O
O	791	800	HIF1alpha	HIF1alpha	NN	B-NP
O	800	801	,	,	,	O
O	802	805	and	and	CC	O
O	806	811	Stat3	Stat3	NN	B-NP
O	812	822	facilitate	facilitate	VBP	B-VP
O	823	828	their	their	PRP$	B-NP
B-Cellular_component	829	836	nuclear	nuclear	JJ	I-NP
O	837	849	localization	localization	NN	I-NP
O	850	853	and	and	CC	O
O	854	861	binding	binding	NN	B-NP
O	862	864	to	to	TO	B-PP
O	865	870	their	their	PRP$	B-NP
O	871	879	specific	specific	JJ	I-NP
O	880	886	motifs	motif	NNS	I-NP
O	887	889	of	of	IN	B-PP
O	890	893	the	the	DT	B-NP
O	894	898	VEGF	VEGF	NN	I-NP
O	899	907	promoter	promoter	NN	I-NP
O	908	911	and	and	CC	O
O	912	918	induce	induce	VB	B-VP
O	919	923	VEGF	VEGF	NN	B-NP
O	924	934	expression	expression	NN	I-NP
O	935	938	via	via	IN	B-PP
O	939	942	two	two	CD	B-NP
O	943	954	independent	independent	JJ	I-NP
O	955	963	pathways	pathway	NNS	I-NP
O	963	964	,	,	,	O
O	965	968	DCN	DCN	NN	B-NP
O	968	969	/	/	SYM	I-NP
O	969	973	EGFR	EGFR	NN	I-NP
O	973	974	/	/	SYM	B-NP
O	974	990	phosphoinositide	phosphoinositide	NN	I-NP
O	990	991	-	-	HYPH	O
O	991	992	3	3	CD	B-NP
O	993	999	kinase	kinase	NN	I-NP
O	999	1000	/	/	SYM	B-NP
O	1000	1003	AKT	AKT	NN	I-NP
O	1004	1007	and	and	CC	I-NP
O	1008	1011	DCN	DCN	NN	I-NP
O	1011	1012	/	/	SYM	B-NP
O	1012	1016	EGFR	EGFR	NN	I-NP
O	1016	1017	/	/	SYM	I-NP
O	1017	1021	ERK1	ERK1	NN	I-NP
O	1021	1022	/	/	SYM	B-NP
O	1022	1023	2	2	CD	B-NP
O	1023	1024	,	,	,	O
O	1025	1037	respectively	respectively	RB	B-ADVP
O	1037	1038	,	,	,	O
O	1039	1041	in	in	IN	B-PP
O	1042	1045	DCN	DCN	NN	B-NP
O	1046	1058	synthesizing	synthesize	VBG	B-VP
B-Cell	1059	1062	MCE	MCE	NN	B-NP
I-Cell	1063	1068	cells	cell	NNS	I-NP
O	1068	1069	.	.	.	O

O	1070	1073	The	The	DT	B-NP
B-Cell	1074	1078	cell	cell	NN	I-NP
O	1079	1083	type	type	NN	I-NP
O	1084	1092	specific	specific	JJ	I-NP
O	1093	1106	glycosylation	glycosylation	NN	I-NP
O	1107	1115	protects	protect	NNS	I-NP
O	1116	1119	Sp1	Sp1	NN	I-NP
O	1120	1123	and	and	CC	I-NP
O	1124	1133	HIF1alpha	HIF1alpha	NN	I-NP
O	1134	1138	from	from	IN	B-PP
O	1139	1149	proteosome	proteosome	NN	B-NP
O	1150	1161	degradation	degradation	NN	I-NP
O	1162	1165	and	and	CC	O
O	1166	1171	plays	play	VBZ	B-VP
O	1172	1174	an	an	DT	B-NP
O	1175	1184	important	important	JJ	I-NP
O	1185	1188	and	and	CC	I-NP
O	1189	1194	novel	novel	JJ	I-NP
O	1195	1199	role	role	NN	I-NP
O	1200	1202	in	in	IN	B-PP
O	1203	1206	the	the	DT	B-NP
O	1207	1217	regulation	regulation	NN	I-NP
O	1218	1220	of	of	IN	B-PP
O	1221	1225	VEGF	VEGF	NN	B-NP
O	1226	1228	in	in	IN	B-PP
O	1229	1232	DCN	DCN	NN	B-NP
O	1233	1244	transfected	transfecte	VBN	I-NP
B-Cell	1245	1248	MCE	MCE	NN	I-NP
I-Cell	1249	1254	cells	cell	NNS	I-NP
O	1254	1255	.	.	.	O

O	1256	1265	Induction	Induction	NN	B-NP
O	1266	1268	of	of	IN	B-PP
O	1269	1280	gelatinases	gelatinas	NNS	B-NP
O	1281	1282	(	(	(	O
O	1282	1288	matrix	matrix	NN	B-NP
O	1289	1306	metalloproteinase	metalloproteinase	NN	I-NP
O	1307	1308	2	2	CD	B-NP
O	1309	1312	and	and	CC	I-NP
O	1313	1314	9	9	CD	I-NP
O	1314	1315	)	)	)	O
O	1315	1316	,	,	,	O
O	1317	1320	the	the	DT	B-NP
O	1321	1327	serine	serine	NN	I-NP
O	1328	1336	protease	protease	NN	I-NP
O	1337	1343	tissue	tissue	NN	I-NP
O	1344	1355	plasminogen	plasminogen	NN	I-NP
O	1356	1365	activator	activator	NN	I-NP
O	1366	1369	and	and	CC	O
O	1370	1377	plasmin	plasmin	NN	B-NP
O	1378	1380	by	by	IN	B-PP
O	1381	1384	DCN	DCN	NN	B-NP
O	1385	1397	transfection	transfection	NN	I-NP
O	1398	1400	in	in	IN	B-PP
B-Cell	1401	1404	MCE	MCE	NN	B-NP
I-Cell	1405	1410	cells	cell	NNS	I-NP
O	1411	1416	leads	lead	VBZ	B-VP
O	1417	1419	to	to	TO	B-PP
B-Immaterial_anatomical_entity	1420	1433	extracellular	extracellular	JJ	B-NP
O	1434	1445	proteolysis	proteolysis	NN	I-NP
O	1446	1449	and	and	CC	B-PP
O	1450	1452	to	to	TO	B-PP
O	1453	1460	release	release	NN	B-NP
O	1461	1463	of	of	IN	B-PP
O	1464	1470	matrix	matrix	NN	B-NP
O	1470	1471	-	-	HYPH	B-NP
O	1471	1476	bound	bind	VBN	I-NP
O	1477	1481	VEGF	VEGF	NN	I-NP
O	1482	1485	and	and	CC	I-NP
O	1486	1496	activation	activation	NN	I-NP
O	1497	1499	of	of	IN	B-PP
O	1500	1512	angiogenesis	angiogenesis	NN	B-NP
O	1512	1513	.	.	.	O

O	1514	1516	In	In	IN	B-PP
O	1517	1521	this	this	DT	B-NP
O	1522	1527	study	study	NN	I-NP
O	1527	1528	,	,	,	O
O	1529	1531	we	we	PRP	B-NP
O	1532	1543	demonstrate	demonstrate	VBP	B-VP
O	1544	1548	that	that	IN	B-SBAR
O	1549	1552	two	two	CD	B-NP
O	1553	1564	independent	independent	JJ	I-NP
O	1565	1575	downstream	downstream	JJ	I-NP
O	1576	1582	signal	signal	NN	I-NP
O	1583	1591	pathways	pathway	NNS	I-NP
O	1591	1592	,	,	,	O
O	1593	1596	DCN	DCN	NN	B-NP
O	1596	1597	/	/	SYM	I-NP
O	1597	1601	EGFR	EGFR	NN	I-NP
O	1601	1602	/	/	SYM	B-NP
O	1602	1606	ERK1	ERK1	NN	I-NP
O	1606	1607	/	/	SYM	B-NP
O	1607	1608	2	2	CD	B-NP
O	1609	1612	and	and	CC	O
O	1613	1616	DCN	DCN	NN	B-NP
O	1616	1617	/	/	SYM	B-NP
O	1617	1621	EGFR	EGFR	NN	I-NP
O	1621	1622	/	/	SYM	B-NP
O	1622	1638	phosphoinositide	phosphoinositide	NN	I-NP
O	1638	1639	-	-	HYPH	O
O	1639	1640	3	3	CD	B-NP
O	1641	1647	kinase	kinase	NN	I-NP
O	1647	1648	/	/	SYM	B-NP
O	1648	1651	AKT	AKT	NN	I-NP
O	1651	1652	,	,	,	O
O	1653	1660	mediate	mediate	VBP	B-VP
O	1661	1663	up	up	RB	B-ADVP
O	1663	1664	-	-	HYPH	B-NP
O	1664	1674	regulation	regulation	NN	I-NP
O	1675	1678	and	and	CC	I-NP
O	1679	1689	activation	activation	NN	I-NP
O	1690	1692	of	of	IN	B-PP
O	1693	1706	transcription	transcription	NN	B-NP
O	1707	1714	factors	factor	NNS	I-NP
O	1715	1717	of	of	IN	B-PP
O	1718	1722	VEGF	VEGF	NN	B-NP
O	1723	1727	such	such	JJ	B-PP
O	1728	1730	as	as	IN	I-PP
O	1731	1740	HIF1alpha	HIF1alpha	NN	B-NP
O	1740	1741	,	,	,	O
O	1742	1747	Stat3	Stat3	NN	B-NP
O	1747	1748	,	,	,	O
O	1749	1752	and	and	CC	O
O	1753	1756	Sp1	Sp1	NN	B-NP
O	1757	1760	and	and	CC	O
O	1761	1769	increase	increase	VB	B-VP
O	1770	1774	VEGF	VEGF	NN	B-NP
O	1775	1788	transcription	transcription	NN	I-NP
O	1789	1792	and	and	CC	O
O	1793	1805	angiogenesis	angiogenesis	NN	B-NP
O	1806	1808	in	in	IN	B-PP
B-Cell	1809	1812	MCE	MCE	NN	B-NP
I-Cell	1813	1818	cells	cell	NNS	I-NP
O	1818	1819	.	.	.	O

